After HCC initiation, SHP2 depletion could skew the balance between proliferation and inflammation and lead to an inflammatory phenotype involving STAT3, which might accelerate HCC development, as reported by Bard-Chapeau et al [26]. Here, PTPN11 is linked to hepatocellular carcinoma.